×
Mortality Risk in Patients With Schizophrenia Participating in Premarketing Atypical Antipsychotic Clinical Trials PDF
$ 40.00
Mortality Risk in Patients With Schizophrenia Participating in Premarketing Atypical Antipsychotic Clinical Trials PDF quantity
$ 40.00
×
Past Anabolic-Androgenic Steroid Use Among Men Admitted for Substance Abuse Treatment: An Underrecognized Problem? PDF
$ 40.00
Past Anabolic-Androgenic Steroid Use Among Men Admitted for Substance Abuse Treatment: An Underrecognized Problem? PDF quantity
$ 40.00
×
Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes PDF
$ 40.00
Two-Year Outcome of Vagus Nerve Stimulation (VNS) for Treatment of Major Depressive Episodes PDF quantity
$ 40.00
×
Treatment of Dysthymia With Sertraline: A Double-Blind, Placebo-Controlled Trial in Dysthymic Patients Without Major Depression PDF
$ 40.00
Treatment of Dysthymia With Sertraline: A Double-Blind, Placebo-Controlled Trial in Dysthymic Patients Without Major Depression PDF quantity
$ 40.00
×
Droperidol: Efficacy and Side Effects in Psychiatric Emergencies PDF
$ 40.00
Droperidol: Efficacy and Side Effects in Psychiatric Emergencies PDF quantity
$ 40.00
×
Clinical Outcomes of Intravenous Ketamine Treatment for Depression in the VA Health System PDF
$ 40.00
Clinical Outcomes of Intravenous Ketamine Treatment for Depression in the VA Health System PDF quantity
$ 40.00
×
Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome PDF
$ 40.00
Randomized Controlled Trial of Interventions for Young People at Ultra-High Risk of Psychosis: Twelve-Month Outcome PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart